This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example content
Adverse event reporting can be found at the bottom of the page
Prescribing information can be found at the bottom of the page.
We are delighted to invite you to our ELEVATE MBC Masterclass 2024 to hear UK and international faculty share the latest evidence and their clinical experience in treating MBC patients. Underpinned by the three core pillars of Education, Evidence and Experience, ELEVATE provides an educational and interactive forum for HCPs to discuss key topics at the forefront of MBC management.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines promoted by Pfizer.
This meeting is available to join virtually. There will be local HCPs attending in-person and no travel or accommodation costs will be supported to attend this meeting.
Prescribing information can be found at the bottom of the page.
We are delighted to invite you to our ELEVATE MBC Masterclass 2024 to hear UK and international faculty share the latest evidence and their clinical experience in treating MBC patients. Underpinned by the three core pillars of Education, Evidence and Experience, ELEVATE provides an educational and interactive forum for HCPs to discuss key topics at the forefront of MBC management.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines promoted by Pfizer.
This meeting is available to join virtually. There will be local HCPs attending in-person and no travel or accommodation costs will be supported to attend this meeting.
Chair - Stephen Johnston - Professor
Break Out Into Sessions
Virtual Event with Faculty
SPOKE Venue with Pfizer Host
No Biography Available
Ibrance®(palbociclib)
Talzenna®▼(talazoparib tosylate)
Tukysa®▼(tucatinib)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024